MeSH term
Frequency | Condition_Probility | Aged | 3 | 0.0 |
Humans | 35 | 0.0 |
Animals | 19 | 0.0 |
Ephrin-B2 | 7 | 50.0 |
Macromolecular Substances | 2 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Protein Binding/physiology | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 3 | 1.0 |
Receptor, EphB2 | 21 | 100.0 |
Cells, Cultured | 5 | 0.0 |
Ligands | 5 | 0.0 |
Models, Biological | 2 | 0.0 |
Phosphorylation | 13 | 0.0 |
Receptor, EphB4 | 3 | 25.0 |
Receptors, Eph Family | 4 | 30.0 |
Amino Acid Sequence | 10 | 0.0 |
Cell Line | 5 | 0.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Signal Transduction | 9 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Transfection | 3 | 0.0 |
DNA Primers | 3 | 0.0 |
Ephrin-B3 | 2 | 40.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Membrane Proteins/*biosynthesis | 2 | 3.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
COS Cells | 5 | 0.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
Ephrin-B1 | 8 | 44.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Rats | 3 | 0.0 |
Time Factors | 3 | 0.0 |
ras Proteins/*metabolism | 3 | 1.0 |
Actins/metabolism | 3 | 0.0 |
Chick Embryo | 4 | 0.0 |
Mice | 12 | 0.0 |
Signal Transduction/*physiology | 3 | 0.0 |
src Homology Domains | 3 | 0.0 |
Binding Sites | 5 | 0.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 1.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Male | 6 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Ephrin-B2/*metabolism | 2 | 50.0 |
Female | 5 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Exons | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Membrane Proteins/*metabolism/pharmacology | 2 | 25.0 |
Cell Movement/*physiology | 2 | 0.0 |
Culture Techniques | 2 | 0.0 |
3T3 Cells | 3 | 0.0 |
Cell Adhesion/physiology | 3 | 1.0 |
Kidney/cytology/metabolism | 2 | 2.0 |
Peptide Mapping | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/chemistry/genetics/*metabolism | 2 | 9.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Tyrosine/chemistry/*metabolism | 2 | 20.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 3 | 2.0 |
Base Sequence | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
